176 related articles for article (PubMed ID: 31303770)
21. Prognostic Significance of Preoperative Albumin to Alkaline Phosphatase Ratio in Patients with Glioblastoma.
Li J; Zuo M; Zhou X; Xiang Y; Zhang S; Feng W; Liu Y
J Cancer; 2021; 12(19):5950-5959. PubMed ID: 34476009
[No Abstract] [Full Text] [Related]
22. The impact of serum albumin-to-alkaline phosphatase ratio in cervical cancer patients treated with definitive chemoradiotherapy.
Onal C; Gultekin M; Yavas G; Oymak E; Yuce Sari S; Guler OC; Yigit E; Yildiz F
J Obstet Gynaecol; 2022 Aug; 42(6):2426-2432. PubMed ID: 35653776
[TBL] [Abstract][Full Text] [Related]
23. Decreased albumin-to-alkaline phosphatase ratio predicted poor survival of resectable gastric cancer patients.
Wang Y; Xiong F; Yang J; Xia T; Jia Z; Shen J; Xu C; Feng J; Lu Y
J Gastrointest Oncol; 2021 Aug; 12(4):1338-1350. PubMed ID: 34532092
[TBL] [Abstract][Full Text] [Related]
24. Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma: a propensity score matching analysis.
Zhang K; Dong S; Jing YH; Gao HF; Chen LY; Hua YQ; Chen H; Chen Z
BMC Cancer; 2020 Jun; 20(1):541. PubMed ID: 32517802
[TBL] [Abstract][Full Text] [Related]
25. Prognostic role of pretreatment albumin-to-alkaline phosphatase ratio in locally advanced laryngeal and hypopharyngeal cancer: Retrospective cohort study.
Wu J; You K; Jiang Y; Shen T; Song J; Chen C; Liu Y
J Cancer; 2021; 12(20):6182-6188. PubMed ID: 34539891
[No Abstract] [Full Text] [Related]
26. Albumin-to-alkaline phosphatase ratio as a promising indicator of prognosis in human cancers: is it possible?
An L; Yin WT; Sun DW
BMC Cancer; 2021 Mar; 21(1):247. PubMed ID: 33685425
[TBL] [Abstract][Full Text] [Related]
27. Albumin-to-Alkaline Phosphatase Ratio as an Independent Prognostic Factor for Overall Survival of Advanced Hepatocellular Carcinoma Patients without Receiving Standard Anti-Cancer Therapies.
Cai X; Chen Z; Chen J; Ma X; Bai M; Wang T; Chen X; Wu D; Wei L; Li X; Lin Q; Wen J; Ruan D; Lin Z; Dong M; Wu X
J Cancer; 2018; 9(1):189-197. PubMed ID: 29290785
[No Abstract] [Full Text] [Related]
28. Albumin-to-Alkaline Phosphatase Ratio is an Independent Prognostic Indicator in Combined Hepatocellular and Cholangiocarcinoma.
Zhang F; Lu S; Tian M; Hu K; Chen R; Zhang B; Ren Z; Shi Y; Yin X
J Cancer; 2020; 11(17):5177-5186. PubMed ID: 32742464
[No Abstract] [Full Text] [Related]
29. Albumin-to-Alkaline Phosphatase Ratio as a Novel Prognostic Factor in Patients Undergoing Nephrectomy for Non-Metastatic Renal Cell Carcinoma: Propensity Score Matching Analysis.
Won I; Shim SR; Kim SI; Kim SJ; Cho DS
Clin Genitourin Cancer; 2022 Jun; 20(3):e253-e262. PubMed ID: 35241381
[TBL] [Abstract][Full Text] [Related]
30. Low albumin-to-alkaline phosphatase ratio is associated with inferior prognosis in patients with head and neck cancer underwent concurrent chemoradiation: A propensity score-matched analysis.
Kim D; Ki Y; Kim W; Park D; Joo J; Jeon H; Nam J
J Cancer Res Ther; 2023; 19(5):1340-1344. PubMed ID: 37787305
[TBL] [Abstract][Full Text] [Related]
31. Albumin-to-alkaline phosphatase ratio as a novel prognostic indicator in patients undergoing peritoneal dialysis: a propensity score matching analysis.
Xia W; Hua X; Sun D; Xie X; Hu H
Front Med (Lausanne); 2024; 11():1302603. PubMed ID: 38698782
[TBL] [Abstract][Full Text] [Related]
32. Albumin-to-alkaline phosphatase ratio as a predictor of tumor recurrence and prognosis in patients with early-stage hepatocellular carcinoma undergoing radiofrequency ablation as initial therapy.
Zhang F; Lu SX; Hu KS; Gan YH; Chen Y; Ge NL; Yang BW; Zhang L; Chen RX; Ren ZG; Yin X
Int J Hyperthermia; 2021; 38(1):1-10. PubMed ID: 33400889
[TBL] [Abstract][Full Text] [Related]
33. Albumin-to-Alkaline Phosphatase Ratio as a Novel Prognostic Marker of Nivolumab Monotherapy for Previously Treated Metastatic Renal Cell Carcinoma.
Yoshino M; Ishihara H; Ishiyama Y; Tachibana H; Toki D; Yamashita K; Kobayashi H; Fukuda H; Yoshida K; Takagi T; Iizuka J; Ishida H; Kondo T; Tanabe K
In Vivo; 2021; 35(5):2855-2862. PubMed ID: 34410978
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Value of Preoperative Albumin-to-Alkaline Phosphatase Ratio in Patients with Muscle-Invasive Bladder Cancer After Radical Cystectomy.
Zhao M; Zhang M; Wang Y; Yang X; Teng X; Chu G; Wang X; Niu H
Onco Targets Ther; 2020; 13():13265-13274. PubMed ID: 33402835
[TBL] [Abstract][Full Text] [Related]
35. Association Between the Pretreatment Albumin-to-Alkaline Phosphatase Ratio and Clinical Outcomes in Patients With Bladder Cancer Treated With Radical Cystectomy: A Retrospective Cohort Study.
Li S; Lu S; Liu X; Chen X
Front Oncol; 2021; 11():664392. PubMed ID: 33959511
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of dynamic albumin-to-alkaline phosphatase ratio in limited stage small-cell lung cancer.
Li X; Li B; Zeng H; Wang S; Sun X; Yu Y; Wang L; Yu J
Future Oncol; 2019 Mar; 15(9):995-1006. PubMed ID: 30644319
[TBL] [Abstract][Full Text] [Related]
37. Albumin-To-Alkaline Phosphatase Ratio as a Novel and Promising Prognostic Biomarker in Patients Undergoing Esophagectomy for Carcinoma: A Propensity Score Matching Study.
Zhu X; Chen D; Li S; Zhang W; Li Y; Wang X; Zhou J; Wen Z
Front Oncol; 2021; 11():764076. PubMed ID: 34746006
[TBL] [Abstract][Full Text] [Related]
38. Albumin-to-Alkaline Phosphatase Ratio: Does It Predict Survival in Grade 1 and Grade 2 Neuroendocrine Tumors?
Acikgoz Y; Bal O; Dogan M
Pancreas; 2021 Jan; 50(1):111-117. PubMed ID: 33370032
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Value of Albumin-to-Alkaline Phosphatase Ratio in Hepatocellular Carcinoma Patients Treated with Liver Transplantation.
Li H; Wang L; Chen L; Zhao H; Cai J; Yao J; Zheng J; Yang Y; Wang G
J Cancer; 2020; 11(8):2171-2180. PubMed ID: 32127944
[No Abstract] [Full Text] [Related]
40. Prognostic Value of a Nomogram Based on the Dynamic Albumin-to-Alkaline Phosphatase Ratio for Patients with Extensive-Stage Small-Cell Lung Cancer.
Li B; Jiang C; Wang R; Zou B; Xie P; Li W; Sun X; Yu J; Wang L
Onco Targets Ther; 2020; 13():9043-9057. PubMed ID: 32982294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
